Waggle needling wields preferable neuroprotective and anti-spastic effects on post-stroke spasticity rats by attenuating γ-aminobutyric acid transaminase and enhancing γ-aminobutyric acid.
Journal
Neuroreport
ISSN: 1473-558X
Titre abrégé: Neuroreport
Pays: England
ID NLM: 9100935
Informations de publication
Date de publication:
10 07 2020
10 07 2020
Historique:
pubmed:
27
5
2020
medline:
19
8
2021
entrez:
27
5
2020
Statut:
ppublish
Résumé
Waggle needling, a classical anti-spastic needling technique characterized by combination of acupuncture with joint movement, has gained increasing popularity of spasticity treatment in China. This study was designed to compare the anti-spastic effect of waggle needling to the routine needling and to explore its underlying mechanism. We established post-stroke spasticity model based on ischemia stroke operation (middle cerebral artery occlusion). Rats were divided into six groups: normal control group, sham-operated control group, ischemia stroke model group, waggle needling group, routine needling group and baclofen group. Neurological function and muscle tone were assessed by the Zea Longa score and modified Ashworth scale, respectively. Indirect muscle tone was testified with electrophysiological recording. Cerebral infarction was measured by 2,3,5-triphenyltetrazolium chloride staining. The concentrations and expressions of γ-aminobutyric acid transaminase (GABAT) and γ-aminobutyric acid (GABA) were detected by enzyme-linked immunosorbent assay and western blot assay. Waggle needling markedly alleviated neurological deficits, decreased cerebral infarction and eased muscle tone; simultaneously, attenuated GABAT and enhanced GABA expression in the cortical infarct regions in comparison with the routine needling (P < 0.01), yet showed similar therapeutic effect to the baclofen group (P > 0.05). These results preliminary supported that waggle needling as a potential promising non-pharmacological intervention for the treatment of cerebral ischemia and spasticity.
Identifiants
pubmed: 32453018
doi: 10.1097/WNR.0000000000001471
pmc: PMC7289130
pii: 00001756-202007010-00005
doi:
Substances chimiques
gamma-Aminobutyric Acid
56-12-2
4-Aminobutyrate Transaminase
EC 2.6.1.19
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
708-716Références
J Tradit Chin Med. 2014 Oct;34(5):566-71
pubmed: 25417407
Stroke. 2018 Sep;49(9):2129-2137
pubmed: 30354975
Indian J Exp Biol. 2012 Jun;50(6):391-7
pubmed: 22734249
Front Hum Neurosci. 2015 Apr 10;9:192
pubmed: 25914638
Mol Med Rep. 2015 Oct;12(4):5957-62
pubmed: 26260947
Curr Med Chem. 2014;21(28):3294-309
pubmed: 24934345
Biomed Pharmacother. 2016 Jul;81:402-410
pubmed: 27261619
Int J Neurosci. 2013 Aug;123(8):575-81
pubmed: 23509968
Dev Med Child Neurol. 2015 Jul;57(7):611-617
pubmed: 25558043
Stroke. 2010 Feb;41(2):319-24
pubmed: 20044535
Zhongguo Zhen Jiu. 2016 Oct 12;36(10):1013-1017
pubmed: 29231517
Disabil Rehabil. 2005 Jan 7-21;27(1-2):2-6
pubmed: 15799140
Epilepsia. 2001;42 Suppl 3:8-12
pubmed: 11520315
Phys Ther. 1987 Feb;67(2):206-7
pubmed: 3809245
Neurosci Lett. 2005 Aug 5;383(3):317-21
pubmed: 15955428
Muscle Nerve. 2003 Feb;27(2):157-64
pubmed: 12548522
Eur J Phys Rehabil Med. 2019 Dec;55(6):754-760
pubmed: 30868834
Phys Med Rehabil Clin N Am. 2018 Aug;29(3):529-536
pubmed: 30626513
Front Neurosci. 2019 Mar 11;13:147
pubmed: 30914909
Neural Regen Res. 2018 Jun;13(6):1013-1018
pubmed: 29926828
Ann Phys Rehabil Med. 2019 Jul;62(4):265-273
pubmed: 29042299
Zhongguo Zhen Jiu. 2012 Jul;32(7):582-6
pubmed: 22997781
Brain Res. 1999 Aug 7;837(1-2):229-35
pubmed: 10434007
Trials. 2012 Apr 21;13:42
pubmed: 22520963